HomeMedical SpecialtiesCardiologyRemote control treatment for irregular heart beats

Remote control treatment for irregular heart beats

Published on

Sunnybrook is the first centre in Canada to use a new remote control system for treating arrhythmia that is more effective and safer for patients than other options.

“Adding this technology to our minimally invasive arrhythmia lab, which is already cutting-edge with its use of robotic imaging-guided technology, is further enhancing the precision and safety of heart procedures,” says Dr. Eugene Crystal, cardiologist and Director of Arrhythmia Services at Sunnybrook’s Schulich Heart Centre. “We can now access really challenging areas of the heart chambers, which results in greater accuracy during ablation and a reduced risk of complications for patients.”

 MORE: THE DIABETES EPIDEMIC

The VdriveTM system from Stereotaxis is the latest addition to Sunnybrook’s arrhythmia suite that treats about 300 patients a year for irregular heartbeats that occur when the electricity that flows through the heart to trigger the pumping action “short circuits”, or gets blocked, and disturbs the heart’s normal rhythm. Heart palpitations, fatigue, dizziness, chest pain and shortness of breath are all symptoms, which if left untreated can lead to heart attack and stroke.

The sophisticated GPS-like technology controls powerful magnets near the patient to map a pathway through a patient’s blood vessels and heart to the diseased heart tissue. The magnets lead a soft catheter gently along this pathway by guiding its magnetic tip, precisely identifying the location of the faulty electrical site in each patient. Clinicians from the Schulich Heart Centre then ablate, or destroy, damaged heart tissue that causes the electrical malfunction to restore a regular heart rhythm.

MORE: SOUTHLAKE IMPLANTS WORLDS SMALLEST HEART MONITOR IN CARDIAC PATIENT


“This is win-win technology that greatly benefits both patients and the health care teams looking after them. Patients receive the best care for irregular heart rhythms in the safest possible environment, and they can often go home the same day with such minimally invasive treatment,” adds Dr. Crystal, Associate Professor, Department of Medicine, University of Toronto.

Latest articles

Youth champions become mental health leaders

RNAO’s Youth Wellness Champions Program celebrates a decade of helping students improve mental health...

Nearly 300,000 Ontarians left emergency room without treatment last year

Across Canada, over 1.2 million patients left emergency rooms untreated last year. The number of...

Expanding access to prenatal education with new online modules for high-risk pregnant patients

Expecting a baby can be both exciting and overwhelming, particularly for families navigating a...

UHN’s first Emergency Preparedness Specialist reimagined how to prepare for and respond to emergencies

HN Summary • Trailblazing role: Natasha Bloomberg, UHN’s first Emergency Preparedness Specialist, is retiring after...

More like this

Youth champions become mental health leaders

RNAO’s Youth Wellness Champions Program celebrates a decade of helping students improve mental health...

Nearly 300,000 Ontarians left emergency room without treatment last year

Across Canada, over 1.2 million patients left emergency rooms untreated last year. The number of...

Expanding access to prenatal education with new online modules for high-risk pregnant patients

Expecting a baby can be both exciting and overwhelming, particularly for families navigating a...

UHN’s first Emergency Preparedness Specialist reimagined how to prepare for and respond to emergencies

HN Summary • Trailblazing role: Natasha Bloomberg, UHN’s first Emergency Preparedness Specialist, is retiring after...

Putting patients first and enhancing ED communication

To improve communications and ensure patients feel supported from the moment they enter the...

Research findings could improve outcomes for critically ill patients on ventilators, study findscutting-edge geriatric care insights

A seven-year international, multi-centre clinical trial led by London Health Sciences Centre Research Institute...